chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Employee noticed redness and swelling of upper left arm the day following her AFLURIA vaccine. Also states the vaccine was given below the deltoid are in mid upper left arm. 9/28/2009 10:15 9-10 cm oval reddened area mid upper left arm.
2 hours after vaccine, both eyes started itching severely,  but were not red. I started putting Sustane eye drops in continuously, but did not help. Keeping eyes closed did not help. 18 hours later ( 8am next day, I planned to call eye Dr, but did not, because it started to go away, when I woke up at 8am)  since it was improved, not red eyes.  And I had not been around any cats for months. I could see ok during all this, but itched severely, did not want eyes open.   I wonder if this will occur with next vaccine, I will have eye appt available if I ever need another vaccine.
15 year old that received Moderna; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old that received Moderna) in a 15-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old that received Moderna). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old that received Moderna) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medication use were not provided. In or around 2017, the patient was inoculated with ZOSTAVAX (dose, route of administration, site of administration and lot # were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (Herpes zoster). Shortly after receiving the ZOSTAVAX vaccine, the patient suffered shingles. As a direct and proximate result of the vaccine, the patient's symptoms have resulted in physical limitations not present prior to using the vaccine. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of his (Conflicting information, as patient is reported as a female (female name)) condition. As a result of ZOSTAVAX vaccine, the patient sustained severe and permanent personal injuries.  Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the use of the ZOSTAVAX, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of shingles was considered to be not recovered. Causality assessment was related. Shingles was considered to be disabling. Additional information has been requested.
diagnosed with positive covid test; More than 36 days have past since first shot, delayed second shot; cough; Nasal congestion; Loss of smell; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (diagnosed with positive covid test), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days have past since first shot, delayed second shot), COUGH (cough), NASAL CONGESTION (Nasal congestion) and ANOSMIA (Loss of smell) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (diagnosed with positive covid test), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days have past since first shot, delayed second shot), COUGH (cough), NASAL CONGESTION (Nasal congestion) and ANOSMIA (Loss of smell). At the time of the report, SARS-COV-2 TEST POSITIVE (diagnosed with positive covid test), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days have past since first shot, delayed second shot), COUGH (cough), NASAL CONGESTION (Nasal congestion) and ANOSMIA (Loss of smell) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jan-2021, COVID-19 (other-Unknown positive/non-neutralizing): posiive positive/non-neutralizing (High) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant and treatment details reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow-up received on 23-JUL-2021 , lab data updated.
pain/redness/sore at site, sore arm, myalgia, headache  Narrative:
received only with the diluent; received only with the diluent; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 43-year-old female patient who received Herpes zoster (Shingrix) (batch number PG35Z, expiry date 11th March 2023) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that the patient received a dose of Shingrix vaccine only with the diluent, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up.
15 days post vax, the pt developed eight generalized vesicles on his scalp, forearm, lip and chest. He also experienced an area of induration of about 8.5 X 6.5 cm in diameter at the injection site with lacey appearance, papular rash, pain and redness. It was also noted that the site felt warm to the touch.
Patient's arm was sore and bruised; some of the fluid dripped down her arm/"all of the vaccine came out and dripped down to her wrist"; some of the fluid dripped down her arm/"all of the vaccine came out and dripped down to her wrist"; some of the fluid dripped down her arm/"all of the vaccine came out and dripped down to her wrist"; it hit the bone/ it was given in bone; it hit the bone and after the nurse pulled back the needle, some of the fluid dripped down my arm; "it hit the bone"/When it was given it felt like cracking in her bone; patient's arm was sore and bruised; This is a spontaneous report from a contactable nurse.  A 64-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (lot number: EL3248), via an unspecified route of administration in the left arm, on 16Jan2021 08:15 at SINGLE DOSE for COVID-19 immunization. Patient had no relevant medical history.  The patient's concomitant medications were not reported. The patient stated that during vaccination last Saturday(16Jan2021), "it hit the bone". The nurse pulled back the needle and after that some of the fluid dripped down her arm. Then it was further reported that it was given in bone and "all of the vaccine came out and dripped down to her wrist". Hence, they wanted to know if patient should get it re-administered or get another half dose. Patient's arm was sore and bruised, the first day was so sore but it was getting better. When it was given it felt like cracking in her bone and she thought the needle broke. After the nurse withdrew the needle, she was told it was not broken but said the needle must have gone to the bone. The outcome of event "patient's arm was sore and bruised" was recovering whereas the outcome of all other events was unknown.   No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.
Vasovagal response. Client laid down elevated feet. rested for 5 minutes, sat up for additional 10 minutes and was escorted out by clinic supervisor to vehicle with client's grandmother.
red rash; This case was reported by a pharmacist via call center representative and described the occurrence of red rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced red rash. On an unknown date, the outcome of the red rash was unknown.   It was unknown if the reporter considered the red rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided. The patient had received first dose of Shingrix elsewhere and developed red circumferential rash on arm, large area. The reporter did not have lot or expiration date, as it was given elsewhere.
Fever of 101, body aches, headache, tired. Sleep and ADVIL. Began 12 hours after given vaccine and lasted 24 hours.
Pt. states that after receiving the 2nd dose of Moderna 12/31/2021, started experiencing symptoms 01/01/2022 of headaches and welp running across the Left arm at the injection site. No noted Primary visit/communications. Self-Treating with Tylenol and Benadryl. Covid + 09/13/2021 received Covid Antibodies 09/14/2021.
Patient passed out for about 15 seconds as the patient reports that she had nothing to eat or drink before the vaccine was administered. Patient came to and reports to feel fine after, as she was not light headed, dizzy, etc. Patient stayed in office for about 20 mins after and left feeling fine. Only a GARDASIL-9 was administered at the time of visit, Left arm (IM), 0.5mL vial, LOT: R003557 EXP: 11/20/2020. Patient was given food and water in clinic and then eval by provider then sent home.
tenderness, erythema, cellulitis @ area of inject rt arm; as seen & described by family MD; no temp; Dicloxacillin ordered on 4SEP92;
Patient was given Moderna Booster .27ml lot #031H21A. The vial was improperly handled and was left at room temperature more than the allowed time after the vial was punctured. The vial was at room temperature for 48 hours. The patient was notified and treated right after the incident occurred. The patient did not have any adverse reactions. Moderna manufacturer contacted for guidance.
Red blotchy area, approximately 3x2 inches in size, below the injection site on the left deltoid. Warm to touch. No complaints of itching, pain, shortness of breath, or swelling. Client happened to notice the area when preparing for bed and reported it to the health department at 10:15 am on 10/17/2010.
hearing loss; shingles; Information has been received regarding a case in litigation, referring to a patient of unknown age and gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided. In 2016, the patient was inoculated with zoster vaccine live (ZOSTAVAX) as prescribed and/or administered by a pharmacist, for the long-term prevention of shingles and/or zoster-related conditions (strength, route, frequency, lot# and expiration date were not reported). On an unknown date, subsequent to the zoster vaccine live (ZOSTAVAX) inoculation, the patient was treated by a physician for shingles and the patient sought for additional treatment from a pharmacist for hearing loss. As a direct and proximate result of the patient's zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of shingles and hearing loss was not reported. The reporter considered shingles and hearing loss to be related to zoster vaccine live (ZOSTAVAX). Upon internal review, the event of hearing loss was considered to be medically significant.
GI dx-vomiting, diarrhea, low grade temp, fatigue w/in 24hr et lasting approx 1 noc;no treatment;
Patient presented with vesicular lesions to Rt side of Rt leg at VARIVAX injection site.
EVENT: 5 minutes after receiving 2nd Pfizer vaccine, patient reported she wasn't feeling good. she was already seated, so we had her bend forward with her head between her knees. That wasn't providing enough relief so we had her grip fingers into a fist and tense her arms. Got the patient cool water bottle to put on her neck. After approximately 2 minutes, patient was recovering and drank some water. She sat up again and her eyes started to lose focus and she said her ears were ringing. Had her put her head back down. She was too unstable to have lie down on the floor so we had her elevate her legs on another chair. Syncope symptoms resolved but patient said she was starting to have what she believed was a panic attack. Tried to have patient list 5 things she could see, hear, etc, but she was too anxious to do so. Asked patient about school/summer break and she started to relax. After 15 minutes of additional observation, patient was able to stand by herself. Guardian walked with her through the store for a few minutes before leaving.
Autism regression 12/16/08-records received for DOS 9/5/08-developmental concerns regarding autistic with seizure during night. Vaccines received. Assessment: well baby exam.  Visit 11/14/08-C/O runny nose, nasal congestion, coughing, poor appetite, not sleeping well due to congestion. Assessment: Reactive airway disease. URI, acute. 11/19/08-C/O congestion and eye drainage. Assessment:sinusitis. Follow up received 03/11/2010. She continues to have developmental regression and fevers.
Herpes zoster (shingles) in T4-5 dermatome on right side, starting 10 days after second vaccination.  Patient prescribed a 7 day course of acyclovir with resolution of symptoms within 2 weeks.
11-04-08 Legs aching then general aches, weak and dizzy.  Noon temp 105 degree F orally.  Called Dr. but unable to reach.  Called CCHD and told to use cool packs and Tylenol or ibuprofen and to go to the ER if doesn't keep temp down.  4 p.m. temp 102.4 F 2:30 p.m. Dr. called adn gave antibiotics.  11-3-08 PM able to eat.  11-6-08 still a bit dizzy and weak.  11-6-08 BP 144/69 P 88.
Pt recvd 2nd dose of recomb 18JAN91 & 5 to 7 min following pt c/o salty taste in back of mouth;
A report was received from a health care professional on 10/17/2003 concerning a 3 year old female vaccinee who received Fluvirin on 10/17/03 The vaccinee experienced no adverse symptoms. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 1 11/14/2003: the follow up report received from a health care professional indicating that the vaccinee had not experienced any adverse events.
welts look like bug bites; how do i treat my rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (welts look like bug bites) and RASH (how do i treat my rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (welts look like bug bites) and RASH (how do i treat my rash). At the time of the report, URTICARIA (welts look like bug bites) and RASH (how do i treat my rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not reported.
tested positive for the COVID-19; tested positive for the COVID-19; This is a spontaneous report from a Pfizer sponsored program received from a contactable consumer (patient himself). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Feb2021 (Batch/Lot Number: EN6200; Expiration Date: 12Jun2021) as dose 2, single and via an unspecified route of administration on 26Jan2021 (Batch/Lot Number: EL1283; Expiration Date: Apr2021) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was asking if he can get the third booster shot of the vaccine since he already received the first dose and second dose but after getting those two doses, he tested positive for COVID-19 on 03Aug2021. Outcome of events was unknown.
High pitched intermittent crying for 1 1/2 hr after vaccine was given. Slight swelling of the right thigh but no fever.
I noticed a hearing distortion within the hour after taking the Booster Shot.  The distortion has worsened over the past year.  The distortion is a loudness of the outside sounds that becomes distorted.
Entire body aching, sinuses inflamed and filling with mucus, headache, gas, no energy, coughing, temporary scratchy throat, sneezing.
Patient had vagal response after being given second dose of Pfizer biotech. Patient's vitals were taken and hypotensive. Systolic Blood pressure 80s and patient reporting feeling weak and dizzy. Directed to Urgent Care for further evaluation.
SOB, diarrhea, nausea, vomiting, dizziness, light-headedness
A sharp muscle ache in bicep from shoulder to elbow that began a few days after vaccine administration following a short period of normal muscle soreness at injection site. Pain has been consistent without any improvement for 4 months. Pain is strong enough to wake her up at night and prevent her from reaching upwards.
the day after his daughters arm was red at the injection site; there was an issue with their freezer and it was supposed to hold the vaccine that was given frozen but instead it was liquid and they still had given it to her; it was supposed to hold the vaccine that was given frozen but instead it was liquid and they still had given it to her; This spontaneous report was received from a consumer, referring to his daughter a female patient of unknown age. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were unknown by the reporter.  In May 2020, the patient at the age of 16 months old, was vaccinated with a dose of measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (PROQUAD) injection, administered on an unspecified arm, as prophylaxis (dosage, vaccination scheme, route of administration, lot number and expiration date were unknown by the reporter).  On an unspecified day in May 2020 (also reported as "the day after"), the patient's arm was red at the injection site (injection site erythema). The father stated that, it had been like that for a month now. It was unknown by the reporter if the patient sought medical attention, if laboratory diagnostic studies were performed or if treatment was given for the adverse event.   On an unspecified date in July 2020 (also reported as "2 months later"), the father received a call from the office where the patient had gotten the vaccine. They informed him that, there was an issue with their freezer, it was supposed to hold the given vaccine frozen, but instead it was liquid, and still it was administered to his daughter (product storage error and product physical consistency issue). In addition, the father wanted to know if this could be a major problem for the child.   The outcome of the event injection site erythema was not reported. The causal relationship between the aforementioned event and therapy with measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (PROQUAD), was not provided.
Patient did not have any adverse events, instead patient was given the wrong type of vaccine. Patient received a regular Covid-19 vaccine instead of Bivalent immunization.
I woke up around 5:00 AM with a little twinge in my back by my kidney. I got up a little later to go to the bathroom. While I was there I broke out in a cold sweat. I finished up and sat down on the stool we have. I sit there for a while, my ears ringing and I realize that I can't see, and the next thing I know I'm on the floor and my head hurts where it hit it on the floor. The pain in my kidney area gets worse but about an hour later, subsides quickly. I went back to bed for a while and slept it off.
Left thigh swelling, no erythema, no induration, no pain at site of injection.  Normal activity but some ROM.  Thigh size 2.5 irregular on the right.
Administrated infant  Beyfortus (RSV) vaccine to an adult.  Notified patient. Patient has no symptoms or side effects.
Information has been received from a health professional concerning a 12 month old white male patient with no known allergies who on 17-Mar-2005 was vaccinated SC into the left thigh with a first dose of measles virus vaccine live (Endora-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (Lot # 644844/0771P). Secondary concomitant therapy included a first SC dose of varicella virus vaccine live (lot # 648308/0276P) into the right thigh. It was reported that there was no illness at the time of vaccination. On 18-Mar-2005 the patient's mother called the office and reported that the patient had developed "white welts with red circles" on the back, face, abdomen and extremities. The patient had no fever. The physician advised the patient to take diphenhydramine hydrochloride (BENADRYL) 1 teaspoon po every 6 hours. According to the reporter the rash seemed worse and the child seemed to be quivering. The patient was examined in the emergency room on 19-Mar-2005 and had no fever, no respiratory symptoms and was diagnosed with urticaria. The patient was given diphenhydramine hydrochloride (BENADRIYL) 5mg every 4 to 6 hours as needed and was discharged home in good condition. It was reported that the patient had recovered.  Additional information is not expected.
about 2wk p/vax pt began to have sharp-knife like stabbing pains in upper rt arm;pt had pneumonia shot pains went away present but con occurring;c/o pain tetanus rt arm;
SOB, HEADACHE, DIZZINESS, NAUSEA, LEFT ARM NUMBNESS WENT TO ER.